United States· US:85424-006_3afa5e69-c286-fd73-e063-6294a90a93f9
RoyceDerm Stye Relief Eye Spray.
A medicinal product containing hypochlorous acid, registered in United States by RoyceDerm LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HYPOCHLOROUS ACID
- Manufacturer
- RoyceDerm LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1185424-006-01
- ndc118542400601100 g in 1 BOTTLE, SPRAY (85424-006-01)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hypochlorous acid in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a7703ef3-e2e6-41f9-bfef-f702a043bf6a GET /v1/drugs/a7703ef3-e2e6-41f9-bfef-f702a043bf6a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": ".01",
"substance": "HYPOCHLOROUS ACID",
"productndc": "85424-006",
"dosage_form": "SPRAY",
"dea_schedule": null,
"strength_unit": "g/100g",
"application_number": "505G(a)(3)",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about hypochlorous acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.